Health First Holmes Regional Medical Center

Melbourne, Florida 32901-3276

0 studies enrolling now · 35 studies all time

What they study most

Acute Myocardial Infarction, Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Cognitive/Functional Effects, Colorectal Cancer, Coronary Artery Disease, Diarrhea, Drug/Agent Toxicity by Tissue/Organ, Head and Neck Cancer, Hypertension, Ischemic Stroke

Studies at this site

• Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) — Completed
• Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy — Completed
• Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases — Completed
• Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer — Completed
• Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme — Completed
• Radiation Therapy Followed by Carmustine in Treating Patients Who Have Supratentorial Glioblastoma Multiforme — Completed
• Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum — Completed
• Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer — Completed
• External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• Melatonin and Radiation Therapy in Treating Patients With Brain Metastases — Completed
• Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer — Completed
• Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy — Completed
• Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer — Completed
• Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer — Completed
• Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II) — Completed
• Talc in Treating Patients With Malignant Pleural Effusion — Completed
• Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer — Completed
• Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer — Completed
• Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer — Completed
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer — Completed
• Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer — Completed
• Clevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP) — Completed
• Clevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG) — Completed
• Brachytherapy in Treating Patients With Prostate Cancer — Completed
• Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma — Completed
• Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer — Completed
• Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases — Completed
• Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer — Completed
• Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer — Completed
• Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer — Completed
• Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme — Completed
• Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer — Completed
• Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma — Completed
• Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma — Completed
• Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2) — Completed